Data Descriptor presents urinary metabolite measurements in children with ASD, supporting further analysis and comparisons.
This Data Descriptor presents an anonymized, shuffled dataset of creatinine-normalized urinary metabolite measurements from 73 Bulgarian children with autism spectrum disorder (ASD), released to support reuse in secondary analyses and cross-cohort comparisons. The public release represents a pathway-oriented 24-marker subset from a broader urinary diagnostic panel, assembled as a self-contained resource for investigators working in these metabolic domains. Spot urine results are provided as individual-level values after creatinine normalization; for trimethylamine, values below the limit of quantification (LOQ) were replaced with LOQ/2. The deposit contains measurements for 24 urinary markers grouped into three functional classes (neurotransmitters and aromatic amino acid precursors; one-carbon/methylation and vitamin-related metabolites; and energy metabolism/organic acids with microbiome-related amines). The underlying cohort comprised children aged 3–13 years, and no contemporaneous neurotypical control group was enrolled. Second-morning, midstream, acid-stabilized spot urine samples were collected within the provider’s workflow; metabolites were measured by LC–MS/MS, and spot urinary creatinine was measured enzymatically for normalization. The release includes the results table in both XLSX and CSV formats, a reference limits and units file for contextual interpretation, a data dictionary, a README, a changelog, and SHA-256 checksums for integrity verification. The public files contain de-identified analytical variables only and omit individual-level demographics, dates, standalone urinary creatinine, and richer clinical metadata to preserve anonymity.
No takes yet. Share an insight, caveat, or question.
Slavov et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: